Boston Scientific Restores Key Operations After Cyberattack
Boston Scientific Corp 1BSX
News
Boston Scientific Won't Meet Guidance Due to Cyberattack
Boston Scientific Working to Restore Shipments After Cyberattack
Boston Scientific Says Cyberattack Disrupting Global Operations — Update
Boston Scientific Says Cyberattack Disrupting Global Operations
Boston Scientific Logs Higher 2Q, Cuts Outlook Ahead of Restructuring
Boston Scientific to Cut Staff in Global Restructuring Program
Boston Scientific Down Over 10%, On Track for Lowest Close Since November 2023 — Data Talk
Boston Scientific Sets $2 Billion Accelerated Stock Buyback
Boston Scientific Buys 34% Stake in MiRus for $1.5 Billion
Boston Scientific to Update Pacemakers in Recall, FDA Says
Boston Scientific Up Over 8%, on Pace for Largest Percent Increase Since March 2020 — Data Talk
Boston Scientific 1Q Net Grows Sharply, Company Cuts 2026 Adjusted EPS View
Boston Scientific Down Nearly 8%, On Pace For Lowest Close Since January 2024 — Data Talk
Boston Scientific Plunges on Disappointing 1Q Outlook Despite 4Q Earnings Beat
Boston Scientific Down Over 17%, on Pace for Largest Percent Decrease Since July 2000 — Data Talk
Boston Scientific Sees More Growth after Earnings, Sales Rise
Half of GLP-1 users ditch their injections - and some are turning to other weight-loss methods instead
Boston Scientific on Pace for Largest Percent Decrease Since April — Data Talk
Boston Scientific is buying Penumbra for $14.5 billion to get into the business of removing blood clots
United States